BCS
Barclays PLC
BCS has a slight edge over MS overall, supported by stronger valuation.
MS
Morgan Stanley
MS has lower modeled downside risk, despite its lower overall score.
BCS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BCS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BCS.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
BCS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.1x | $13.63 | -40% |
| Fair | 8.4x | $22.57 | -1.2% |
| Current | 8.5x | $22.84 | — |
| Expensive | 11x | $29.76 | +30% |
Historical ranges are pointers, not guarantees.
BCS has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
BCS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for BCS, with profitability improving.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
BCS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.69 | +26% |
| Q2 2026 | $2.58 | +18% |
| Q1 2026 | $2.31 | +14% |
| Q4 2025 | $2.26 | +22% |
| Q3 2025 | $2.14 | +44% |
| Q2 2025 | $2.19 | +62% |
| Q1 2025 | $2.02 | +45% |
| Q4 2024 | $1.86 | +29% |
BCS's earnings per share have climbed steadily: $2.69 over the past year, up 26% from the year before, and higher year over year for eight quarters in a row.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over BCS on earnings, with stronger typical year-over-year growth.
BCS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $9.8B | +9.6% |
| Q2 2026 | $11.2B | +23% |
| Q1 2026 | $10.8B | +8.7% |
| Q4 2025 | $9.1B | -0.3% |
| Q3 2025 | $8.9B | +6.4% |
| Q2 2025 | $9.1B | +8.6% |
| Q1 2025 | $10B | +8.4% |
| Q4 2024 | $9.2B | +26% |
BCS's revenue is growing: $9.8B last quarter, up 9.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 31% | +0.3 points |
| Q2 2026 | 39% | +3.7 points |
| Q1 2026 | 35% | 0 points |
| Q4 2025 | 27% | +2 points |
| Q3 2025 | 31% | -3.3 points |
| Q2 2025 | 35% | +4.7 points |
| Q1 2025 | 35% | +2 points |
| Q4 2024 | 25% | +23 points |
BCS's operating margin was 31% last quarter, about level with the same quarter a year ago.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over BCS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over BCS on profitability, with a higher operating margin.
BCS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $0 | $0 |
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | $0 |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
BCS's free cash flow was $0 over the past year, against $0 the year before. Free cash flow isn't a meaningful measure for financial services companies like BCS.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS has the edge over BCS on cash flow, with more consistent year-over-year improvement.
BCS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.2% | -75.1M shares |
| 1 year | -4.4% | -155M shares |
| 3 years | -13% | -495M shares |
| 5 years | -21% | -909M shares |
| Available history | -22% | -942M shares |
BCS has the edge over MS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
BCS hasn't bought back shares in the past year.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has 1.6B diluted shares, down 1.5% from a year ago.
BCS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -23.9x | Net Cash |
| Q2 2026 | -10.7x | Net Cash |
| Q1 2026 | -10.7x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -28.6x | Net Cash |
| Q2 2025 | -12.1x | Net Cash |
| Q1 2025 | -15.3x | Net Cash |
| Q4 2024 | -3.0x | Net Cash |
BCS has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
BCS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 15.1 | Oversold |
BCS's weekly RSI is 40 (neutral) and its Stochastic is 15 (oversold).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
BCS PE vs Financial Services Sector
| Metric | BCS | Sector median | Relative |
|---|---|---|---|
| PE | 8.5x | 13x | 35% below |
| PE % | 51 | 63 | 12 pts below |
BCS has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
BCS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $22.9 | 0.4% below |
| 20 week MA | $25.5 | 10% below |
| 50 week MA | $24.8 | 7.7% below |
| 100 week MA | $21.2 | 7.8% above |
| 200 week MA | $15.2 | 50% above |
BCS has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 50% above its 200-week average.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over BCS on trend strength, trading above more of its moving averages.
BCS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.45 | $8.11 | -14% |
| 2021 | $8.11 | $10.2 | +26% |
| 2022 | $10.2 | $7.79 | -24% |
| 2023 | $7.79 | $7.88 | +1.2% |
| 2024 | $7.88 | $13.3 | +69% |
| 2025 | $13.3 | $25.7 | +94% |
| 2026 YTD | $25.7 | $22.8 | -11% |
BCS has finished higher in four of the last six years, two of them by more than 50%. It's down 11% so far in 2026.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over BCS on returns for 2026, with the stronger performance.